WI Governor Tony Evers Signs Step Therapy Bill with Arthritis Foundation Advocates Looking On Continue reading Wisconsin Step Therapy Reform Bill Signed into Law
In Pennsylvania, we’re working on legislation to streamline patient access to care. And we can’t do it alone. On June 5, Arthritis Foundation Advocates traveled to Harrisburg for a state legislative day. They shared their stories with legislators and asked for support on two important bills. Continue reading Advocates Gather in Harrisburg to Advocate for Patient Protections
It was a historic day for Delaware residents as Gov. John Carney signed the state’s step therapy legislation into law.
Sometimes referred to as “fail first,” step therapy is a process insurance companies use to require patients to try and fail on their preferred drugs before getting the medication originally prescribed by their doctor. This can happen in the middle of a plan year, even if a patient is currently stable on the medication.
Arthritis Foundation Advocates came to the Statehouse to help pass this legislation. Carol Reilly, chair of the Foundation’s state advocacy committee, testified at both the House and Senate hearings. “Step therapy is an important issue for me and for the people of Delaware,” she said. “Too many patients are required to fail on a drug before they get the medication their prescriber thinks is best for them. This new law will help put care back into the hands of the doctors.”
Advocate Kirsti Bonaquisti personally met with over 10 legislators to share her arthritis story. She helped convince legislators to vote in favor of the bill. Her personal experience with step therapy made her want to speak out so that no other patient would go through what she went through.
Championed by Rep. Melissa Minor-Brown, Senate President Pro Tempore David McBride and Senate Majority Leader Nicole Poore, this legislation passed unanimously in both chambers. As a nurse, Rep. Minor-Brown had the personal experience of seeing patients go through step therapy. That experience made this bill more than just another piece of legislation.
We’re grateful to these Advocates and so many others who helped make this legislation a reality. You can take action, just like Carol and Kirsti did, to help us with our federal step therapy legislation. Send a message to your legislator today through our Action Center. You can modify your message and add in your personal experience or send the message we’ve written for you. It’s just that simple! Click here for more information!
The Arthritis Foundation is happy to announce that the Georgia legislature passed a new law this month that will protect Georgians who are living with arthritis. Continue reading New Georgia Law to Prevent Unnecessary Step Therapy Actions
On February 13, 2019, dozens of Capitol Hill staffers joined the Arthritis Foundation, the American College of Rheumatology and other patient organizations for a special Arthritis 101 briefing on arthritis and the military. Approximately one in every three U.S. veterans has doctor-diagnosed arthritis, while the general population stands at one in four, about 25 percent. Continue reading Arthritis 101 Hill Briefing Introduces a New Congress to Arthritis and the Military
On Wednesday, January 23, a group of Georgia Advocates gathered at the state capitol building to talk to legislators about step therapy reform. The event was attended by Advocates from across the state,including a mother and daughter who drove from three hours away to talk about the challenges they’ve faced getting access to their medications. The day included a visit from the bill sponsor, Rep. Sharon Cooper (R-43), a brief overview of current step therapy practices and role playing, as well as meetings with some of Georgia’s legislators.
Our Advocates talked to legislators about step therapy, which is an insurance practice that requires patients to use a lower-cost drug before permitting more expensive treatments, despite a physician’s recommendation. Rep. Cooper shared with our Advocates that her bill will create guardrails, allowing a physician to override a step therapy request if the requested medication will negatively react with a medication the patient is already taking, or if the patient has previously tried and failed that drug.
The bill has just been introduced and will go through the Georgia House and Senate chambers for review and votes. Please take a moment to take action by reaching out to your legislators and asking them to support step therapy reform in Georgia.
Considering a Medicare Advantage plan for 2019?
An important change is coming that you should know about!
The administration recently released guidance that allows Medicare Advantage (MA) plans to use step therapy. This is new for next year and a few health insurers have already said they will institute the policy. In this week’s Take Care blog, we break down the issue to help you make the best choice during open enrollment season. Remember: Medicare open enrollment has already started and continues through December 7. Read on to get the scoop on this change to Medicare Advantage plans.
Mark your calendars! This year’s Live Yes! Advocacy Summit will take place on March 11-12, 2019 in Washington, D.C. and it won’t be a success without your voices from across the country. Join us in the nation’s capitol and share your story with policymakers to break down barriers to care for people with arthritis.
On Thursday, February 1, the Arthritis Foundation and American College of Rheumatology (ACR) – along with seven other health advocacy organizations – will host a briefing on Capitol Hill urging lawmakers to increase research funding at the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH) and the U.S. Department of Defense (DoD) to combat the nation’s leading cause of disability.
New data reveals the stunning impact of arthritis on the U.S. economy. Between 2003 and 2013, the annual cost of arthritis more than doubled and now totals $304 billion in direct and indirect costs, according to a CDC-sponsored study published in the September 2017 edition of Arthritis Care & Research. These figures include both higher medical costs to patients, as well as lost earnings from individuals who are unable to work due to their condition.